ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,631.30
0.58%
S&P ASX All Technology
3,012.90
1.36%
Brent Oil
83.775
0.17%
US Dollar vs AUD
1.52007
-0.12%
Bitcoin
59,729.09
1.03%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NRX Pharmaceuticals Inc (NRXP)

  7. NRX Pharmaceuticals Inc (NRXP) News

NRXP NRX Pharmaceuticals Inc

2.12
-0.06 (-2.75%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
NRX Pharmaceuticals Inc NRXP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.06 -2.75% 2.12 09:45:17
Open Price Low Price High Price Close Price Previous Close
2.12 1.90 2.26 2.06 2.18
more quote information »

Recent News

Date Time Source Heading
30/4/202422:30PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) Announces Promising..
18/4/202422:32PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from..
18/4/202422:30PRNUSNRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million..
18/4/202406:45PRNUSNRx Pharmaceuticals, Inc. Announces Proposed Underwritten..
17/4/202422:30PRNUSNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data..
15/4/202422:30PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of..
08/4/202422:30PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of..
01/4/202423:28PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and..
28/3/202423:03PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth..
28/3/202423:00PRNUSNRx Pharmaceuticals Announces Reverse Stock Split to..
27/3/202407:03PRNUSUPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth..
25/3/202423:30PRNUSNRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan..
22/3/202407:02PRNUSNRx Pharmaceuticals to Report Fourth Quarter and Full Year..
22/3/202404:57PRNUSNRx Pharmaceuticals Announces Results of the Vote Held..
12/3/202422:49PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Initiates Strategy to..
12/3/202408:16EDGAR2Form DEF 14A - Other definitive proxy statements
11/3/202423:30PRNUSNRx Pharmaceuticals (NASDAQ:NRXP) Completes Memorandum of..
07/3/202408:08EDGAR2Form 8-K - Current report
05/3/202400:30PRNUSNRx Pharmaceuticals (NASDAQ: NRXP) Announces Last Patient,..
02/3/202400:30PRNUSNRx Pharmaceuticals Announces Definitive Purchase Agreement..
29/2/202409:09EDGAR2Form 8-K - Current report
29/2/202402:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/2/202402:49PRNUS/C O R R E C T I O N -- NRx Pharmaceuticals, Inc./
28/2/202400:54PRNUSNRx Pharmaceuticals, Inc. Announces Pricing of $1.5 Million..
27/2/202409:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/2/202408:01PRNUSNRx Pharmaceuticals, Inc. Announces Proposed Underwritten..
27/2/202400:30PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) Launches HOPE..
21/2/202400:30PRNUSNRx Pharmaceuticals (Nasdaq:NRXP) to Launch HOPE..
15/2/202408:30EDGAR2Form 8-K - Current report
14/2/202422:03EDGAR2Form 8-K - Current report
13/2/202400:30PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Advance..
10/2/202400:30PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Reports Comments by..
05/2/202422:48PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces the..
03/2/202408:37EDGAR2Form 8-K - Current report
24/1/202408:16EDGAR2Form 8-K - Current report
22/1/202422:48PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces..
17/1/202422:48PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces Receipt..
17/1/202410:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/1/202423:25DJNNRx Pharmaceuticals Gets Fast-Track Designation for NRX-101..
16/1/202422:48PRNUSNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) Announces FDA..
03/1/202400:45PRNUSNRx Pharmaceuticals (Nasdaq: NRXP) to Present Keynote..
02/1/202422:48PRNUSNRx Pharmaceuticals (Nasdaq: NRXP) Demonstrates Compliance..
30/12/202308:30EDGAR2Form PRE 14A - Other preliminary proxy statements
30/12/202308:15EDGAR2Form 8-K - Current report
27/12/202322:48PRNUSNRx Pharmaceuticals Announces the Election of Janet..
22/12/202308:05EDGAR2Form 8-K - Current report
20/12/202300:15PRNUSNRx Pharmaceuticals Announces Signing of a Data and..
18/12/202322:48PRNUSNRx Pharmaceuticals Announces FDA Clearance of its..
14/12/202308:02PRNUSNRx Pharmaceuticals Provides Notice of Annual Meeting of..
11/12/202322:48PRNUSNRx Pharmaceuticals to Participate in LifeSci Corporate..

Your Recent History

NASDAQ
NRXP
NRX Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved